Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H. Meyers PA, et al. Among authors: betcher d. J Clin Oncol. 2005 Mar 20;23(9):2004-11. doi: 10.1200/JCO.2005.06.031. J Clin Oncol. 2005. PMID: 15774791 Clinical Trial.
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU 3rd, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA; Children's Oncology Group. Chou AJ, et al. Among authors: betcher dl. Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566. Cancer. 2009. PMID: 19637348 Free PMC article. Clinical Trial.
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE; Children's Oncology Group. Meyers PA, et al. Among authors: betcher d. J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095. J Clin Oncol. 2008. PMID: 18235123 Clinical Trial.
Methotrexate.
O'Marcaigh AS, Betcher DL. O'Marcaigh AS, et al. Among authors: betcher dl. J Pediatr Oncol Nurs. 1993 Oct;10(4):158-60. doi: 10.1177/104345429301000407. J Pediatr Oncol Nurs. 1993. PMID: 8251124 No abstract available.
Ifosfamide.
Burnham N, Betcher D. Burnham N, et al. Among authors: betcher d. J Assoc Pediatr Oncol Nurses. 1987;4(3-4):47-50. doi: 10.1177/104345428700400310. J Assoc Pediatr Oncol Nurses. 1987. PMID: 3437406 No abstract available.
Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.
Wells RJ, Arthur DC, Srivastava A, Heerema NA, Le Beau M, Alonzo TA, Buxton AB, Woods WG, Howells WB, Benjamin DR, Betcher DL, Buckley JD, Feig SA, Kim T, Odom LF, Ruymann FB, Smithson WA, Tannous R, Whitt JK, Wolff L, Tjoa T, Lampkin BC. Wells RJ, et al. Among authors: betcher dl. Leukemia. 2002 Apr;16(4):601-7. doi: 10.1038/sj.leu.2402390. Leukemia. 2002. PMID: 11960339
Cyclosporine.
O'Marcaigh AS, Betcher DL. O'Marcaigh AS, et al. Among authors: betcher dl. J Pediatr Oncol Nurs. 1996 Apr;13(2):98-100. doi: 10.1177/104345429601300209. J Pediatr Oncol Nurs. 1996. PMID: 8854993 No abstract available.
46 results